Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal regulatory protein alpha pseudogene 1 (SIRPAP1) is a pseudogene, meaning it is a non-functional segment of DNA that resembles the functional SIRPA gene but does not produce a protein product. Pseudogenes such as SIRPAP1 are not translated into functional proteins and, consequently, do not serve as receptors, enzymes, transporters, or other typical therapeutic targets. Pseudogenes are generally classified as "genomic fossils"—sequences that resemble known genes but have lost their protein-coding ability or function, typically due to mutations. SIRPAP1 relates to the SIRPA gene, which encodes the functional signal regulatory protein alpha, a cell surface receptor involved in the regulation of immune cell activity. However, SIRPAP1 itself is not functional, making it irrelevant as a therapeutic target. This entry is often listed in genomic databases to annotate all discovered human DNA sequences, but therapeutic research and drug development focus on the protein-coding, functional relatives such as SIRPA—not the pseudogene SIRPAP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal regulatory protein alpha pseudogene 1 (SIRPAP1).